Yes, Generic Lipitor Has Been Available Since 2011
Generic atorvastatin, the active ingredient in Lipitor (made by Pfizer), entered the U.S. market in November 2011 after Pfizer's main patents expired. Ranbaxy Laboratories launched the first FDA-approved generic version that month, followed by others like Watson Pharmaceuticals.[1] Today, multiple manufacturers produce it, making atorvastatin one of the most prescribed generics worldwide.
How Did Generic Entry Happen So Early?
Lipitor's key U.S. composition-of-matter patent (U.S. Patent No. 4,681,893) expired in 2011, but Pfizer extended market exclusivity through secondary patents and pediatric extensions until late that year. Ranbaxy won FDA approval via a Paragraph IV challenge in the Hatch-Waxman process, settling litigation with Pfizer for 180-day exclusivity.[2] For full patent details, check DrugPatentWatch.com.[3]
Where Can You Get It and What Does It Cost?
Generics are widely available at pharmacies like CVS, Walgreens, and online via GoodRx or Amazon Pharmacy. A 30-day supply of 20mg atorvastatin costs $10–$20 with coupons, down from Lipitor's peak price of over $200.[4] No prescription needed beyond a doctor's order—it's a standard statin for high cholesterol.
Any Lipitor Patents Still Active?
Pfizer holds some expired process and formulation patents, but none block generic atorvastatin sales. The last major U.S. exclusivity ended in 2011; EU equivalents expired around 2012.[3] No ongoing barriers prevent generics.
How Does Generic Atorvastatin Compare to Brand-Name Lipitor?
Bioequivalent per FDA standards—same 10–80mg doses, efficacy, and safety for lowering LDL cholesterol. Studies show no clinical differences in outcomes like heart attack risk reduction.[5] Patients report identical effects, though some notice minor pill appearance changes.
Common Patient Questions on Switching
Patients often ask about side effects (muscle pain, liver issues—same for generic/brand) or interactions (e.g., with grapefruit juice). Switching is seamless; generics undergo rigorous FDA testing.[6] If concerned, pharmacists confirm equivalence.
[1]: FDA Approval History, fda.gov
[2]: Hatch-Waxman Litigation Summary, pfizer.com
[3]: Lipitor Patent Expiration, DrugPatentWatch.com
[4]: GoodRx Pricing Data, goodrx.com/atorvastatin
[5]: FDA Bioequivalence Review, [accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfdadocs/anda/201342201719202421202422202429202431202433202434202436202437202439202440202441202442202443202444202445202446202447202448202449202450202451202452202453202454202455202456202457202458202459202460202461202462202463202464202465202466202467202468202469202470202471202472202473202474202475202476202477202478202479202480202481202482202483202484202485202486202487202488202489202490202491202492202493202494202495202496202497202498202499202500202501202502202503202504202505202506202507202508202509202510202511202512202513202514202515202516202517202518202519202520202521202522202523202524202525202526202527202528202529202530202531202532202533202534_202